ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,938 | +700.8% | 75,845 | +652.0% | 0.02% | +633.3% |
| Q1 2023 | $242 | -99.9% | 10,086 | -55.5% | 0.00% | -25.0% |
| Q2 2022 | $357,000 | +61.5% | 22,678 | +280.2% | 0.00% | +300.0% |
| Q4 2021 | $221,000 | -68.7% | 5,965 | -59.6% | 0.00% | -66.7% |
| Q3 2021 | $706,000 | +132.2% | 14,767 | +100.8% | 0.00% | +50.0% |
| Q1 2021 | $304,000 | -60.5% | 7,355 | -59.0% | 0.00% | -60.0% |
| Q3 2020 | $769,000 | +122.9% | 17,931 | +143.0% | 0.01% | +66.7% |
| Q2 2020 | $345,000 | – | 7,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |